The Electronic Health Record is of utmost importance to enable the provision of high-quality collaborative care; one prominent development is openEHR. On the other hand, a systematic approach to support the use of routine data for multi-centre clinical research is becoming increasingly important. One example of this is the extensible architecture for using routine data for additional purposes (eardap) which features comprehensive terminological support. However, as experiences in various medical fields have shown, the terminology-based approach is limited to specialized fields and it is argued that a comprehensive terminology is simply too complex and too difficult to maintain. As the openEHR archetype approach does not rely heavily on big standardized terminologies, it offers more flexibility during standardisation of clinical concepts and overcome the shortcomings of terminology-focused approaches. It is unknown, however, how far the more generic openEHR approach can also enable re-use of routinely collected data for clinical research purposes - the use case for which eardap was designed. We therefore explored the feasibility of using the openEHR approach to support multi-centre research in comparison to eardap. Generally speaking, our results show that both eardap and openEHR are suitable to enable the use of routine data for multi-centre clinical research. As the openEHR approach also ensures open, future-proof Electronic Health Records, we conclude that it is highly desirable that multi-centre clinical trials adopt openEHR.
Download full-text PDF |
Source |
---|
Brain Commun
January 2025
Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA 94158, USA.
The largest risk factor for dementia is age. Heterochronic blood exchange studies have uncovered age-related blood factors that demonstrate 'pro-aging' or 'pro-youthful' effects on the mouse brain. The clinical relevance and combined effects of these factors for humans is unclear.
View Article and Find Full Text PDFJ Viral Hepat
February 2025
Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Dendritic cells are the most potent antigen-presenting cells in immune therapeutic approaches for chronic hepatitis B (CHB) infection. Here, we developed a clinical trial to evaluate the efficacy and safety of autologous HBV vaccine-pulsed DCs and their induced T cells (HPDCT) in CHB patients. This was a randomised, prospective, open-label, multicentre, superiority study and 309 treatment-naive CHB patients were divided into HPDCT plus nucleos(t)ide analogues (NAs) group (n = 84), NAs mono-therapy group (n = 82), HPDCT plus Peg-interferon (Peg-IFN) group (n = 69), Peg-IFN mono-therapy group (n = 74).
View Article and Find Full Text PDFAliment Pharmacol Ther
January 2025
Inflammation and Immunology Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
Introduction: Despite the emergence of drugs to treat irritable bowel syndrome (IBS), improving abdominal pain can still be challenging. αδ ligands, such as gabapentin and pregabalin, are sometimes used off-label to tackle this problem. However, evidence for efficacy is limited, and no large-scale studies have been published.
View Article and Find Full Text PDFERJ Open Res
January 2025
Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Background: Data regarding the effectiveness and safety of endoscopic lung volume reduction with valves (ELVR) in emphysema patients with a very low 6-min walk test (6MWT) are limited. Patients with severe emphysema and very low exercise capacity, as indicated by a 6MWT ≤140 m, are often excluded from clinical studies on ELVR, assuming limited therapeutic benefits and increased complication risk.
Study Designs And Methods: This study utilised data from the Lungenemphysemregister e.
Resusc Plus
January 2025
Department of Clinical Sciences, Anaesthesiology and Intensive Care, Lund University, SE-221 84, Lund, Sweden.
Aim: To explore the impact of age on the discriminative ability of the National Early Warning Score (NEWS) 2 in prediction of unanticipated Intensive Care Unit (ICU) admission, in-hospital cardiac arrest (IHCA) and mortality within 24 hours of Rapid Response Team (RRT) review. Furthermore, to investigate 30- and 90-day mortality, and the discriminative ability of NEWS 2 in prediction of long-term mortality among RRT-reviewed patients.
Methods: Prospective, multi-centre study based on 830 complete cases.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!